Zinc as an anti-tumor agent in prostate cancer and in other cancers
- 16 March 2007
- journal article
- review article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 463 (2) , 211-217
- https://doi.org/10.1016/j.abb.2007.02.033
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Zinc induces ERK-dependent cell death through a specific Ras isoformApoptosis, 2006
- Zinc deficiency potentiates induction and progression of lingual and esophageal tumors in p53-deficient miceCarcinogenesis: Integrative Cancer Research, 2006
- Zinc and Prostate Cancer: A Critical Scientific, Medical, and Public Interest Issue (United States)Cancer Causes & Control, 2005
- Zinc Concentration in Esophageal Biopsy Specimens Measured by X-Ray Fluorescence and Esophageal Cancer RiskJNCI Journal of the National Cancer Institute, 2005
- Zinc stabilizes adenomatous polyposis coli (APC) protein levels and induces cell cycle arrest in colon cancer cellsJournal of Cellular Biochemistry, 2004
- Metallothionein can function as a chaperone for zinc uptake transport into prostate and liver mitochondriaJournal of Inorganic Biochemistry, 2004
- Diet and prostate cancer: a case-control studyEuropean Journal Of Cancer, 1997
- On the inhibition of mitochondrial electron transport by Zn2+ ionsFEBS Letters, 1972
- Inhibition of the respiratory chain by zinc ionsBiochemical and Biophysical Research Communications, 1967
- Über den Stoffwechsel von Tumoren im KörperJournal of Molecular Medicine, 1926